In the BH3 profiling, we exposed eight cases of human MLL-ALL cells to BH3 sensitizer peptides NOXA, HRK and BAD as well as pro-apoptotic activator peptide, BIM. The gene discussed is PMAIP1; the disease is acute lymphoblastic leukemia.